Describing antimicrobial use and reported treatment efficacy in Ontario swine using the Ontario swine veterinary-based Surveillance program

BMC Veterinary Research

Volumn 9, Issue , 2013, Pages

  Glass Kaastra, Shiona K ^a   Pearl, David L ^a   Reid Smith, Richard J ^a,b   McEwen, Beverly ^a   McEwen, Scott A ^a   Amezcua, Rocio ^a   Friendship, Robert M ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

Antimicrobial use; Swine; Treatment efficacy; Treatment failure

Indexed keywords

SUIDAE;

ANTIINFECTIVE AGENT; CEFTIOFUR; CEPHALOSPORIN DERIVATIVE; PENICILLIN DERIVATIVE; TETRACYCLINE;

ANIMAL; ARTICLE; CANADA; HEALTH SURVEY; METHODOLOGY; MICROBIOLOGY; RETROSPECTIVE STUDY; STATISTICS; SWINE; SWINE DISEASE; TREATMENT FAILURE; TREATMENT OUTCOME; VETERINARY MEDICINE;

ANIMALS; ANTI-INFECTIVE AGENTS; CEPHALOSPORINS; ONTARIO; PENICILLINS; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES; SWINE; SWINE DISEASES; TETRACYCLINE; TREATMENT FAILURE; TREATMENT OUTCOME; VETERINARY MEDICINE;

EID: 84888358720     PISSN: None     EISSN: 17466148     Source Type: Journal    
DOI: 10.1186/1746-6148-9-238     Document Type: Article

References (28)

1. McEwen SA, Fedorka-Cray PJ. Antimicrobial use and resistance in animals. CID 2002, 34(3):S93-S106.
2. Glass-Kaastra SK, Pearl DL, Reid-Smith R, McEwen B, Slavic D, Fairles J, McEwen SA. Multiple-class antimicrobial resistance surveillance in swine Escherichia coli F4, Pasteurella multocida and Streptococcus suis isolates from Ontario and the impact of the 2004 - 2006 Porcine Circovirus type-2 Associated Disease outbreak. Prev Vet Med in press.
3. Rothermel CD. Penicillin and macrolide resistance in pneumococcal pneumonia: does resistance affect clinical outcomes?. CID 2004, 38(Suppl 4):S346-S349.
4. Amezcua M, Pearl DL, Friendship RM, McNab WB. Evaluation of a veterinary-based syndromic surveillance system implemented in swine. CJVR 2010, 74:241-251. 2949336, 21197223.
5. Glass-Kaastra SK, Pearl DL, Reid-Smith R, McEwen B, Slavic D, Fairles J, McEwen SA. Assessment of antimicrobial susceptibility data for Escherichia coli F4, Pasteurella multocida and Streptococcus suis isolates from a comprehensive diagnostic veterinary laboratory and recommendations for surveillance system development. Can Vet J in press.
6. Dohoo I, Martin W, Stryhn H. Veterinary Epidemiologic Research 2010, Charlottetown, PEI: VER Inc, 2.
7. Dohoo IR, Tillard E, Stryhn H, Faye B. The use of multilevel models to evaluate sources of variation in reproductive performance in dairy cattle in Reunion Island. Prev Vet Med 2001, 50:127-144. 10.1016/S0167-5877(01)00191-X, 11448500.
8. Rosengren LB, Gow SP, Weese JS. Antimicrobial use and resistance in pigs and chickens: a review of the science, policy and control practices from farm to slaughter - an executive summary. CJIDMM 2010, 31(3):123-124.
9. Government of Canada Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) 2008 - Farm Surveillance in Pigs Preliminary Results: Antimicrobial Use 2010, Guelph (Ontario): Public Health Agency of Canada, Government of Canada.
10. Cho JG, Dee SA, Deen J, Guedes A, Trincado C, Fano E, Jiang Y, Faaberg K, Collins JE, Murtaugh MP, Soo Joo H. Evaluation of the effects of animal age, concurrent bacterial infection, and pathogenicity of porcine reproductive and respiratory syndrome virus on virus concentration in pigs. AJVR 2005, 67:489-493.
11. Van Gucht S, Labarque G, Van Reeth K. The combination of PRRS virus and bacterial endotoxin as a model for multifactorial respiratory disease in pigs. Vet Immunol Immunop 2004, 102:165-178.
12. Canadian Veterinary Medical Association CVMA guidelines on the prudent use of antimicrobial drugs in swine. Can Vet J 2002, 43:420-424. Canadian Veterinary Medical Association.
13. Mathew AG, Upchurch WG, Chattin SE. Incidence of antibiotic resistance in fecal Escherichia coli isolated from commercial swine farms. J Anim Sci 1998, 76:429-434.
14. Health Canada Uses of antimicrobials in food animals in Canada: impact on resistance and Human health. Veterinary Drugs Directorate 2002, http://www.hc-sc.gc.ca/dhp-mps/alt_formats/hpfb-dgpsa/pdf/pubs/amr-ram_final_report-rapport_06-27-eng.pdf, Health Canada.
15. Hsueh KJ, Lee JW, Hou SM, Chen HS, Chang TC, Chu CY. Evaluation on a Streptococcus suis vaccine using recombinant Sao-L protein manufactured by bioreactors as the antigen in pigs. Transbound Emerg Dis 2013, http://dx.doi.org/10.1111/tbed.12067.
16. Baums CG, Valentin-Weigand P. Surface-associated and secreted factors of Streptococcus suis in epidemiology, pathogenesis and vaccine development. Anim Health Res Rev 2009, 10(1):65-83. 10.1017/S146625230999003X, 19558750.
17. Díaz I, Gimeno M, Callén A, Pujols J, López S, Charreyre C, Joisel F, Mateau E. Comparison of different vaccination schedules for sustaining the immune response against porcine reproductive and respiratory syndrome virus. Vet J 2013, http://dx.doi.org/10.1016/j.tvjl.2013.02.008.
18. Zhao Z, Quin Y, Lai Z, Peng L, Cai X, Wang L, Guo X, Yang H. Microbial ecology of swine farms and PRRS vaccine vaccination strategies. Vet Microbiol 2012, 155:247-256. 10.1016/j.vetmic.2011.09.028, 22014373.
19. Fu F, Lang Y, Li X, Chai Z, Tong G, Liu S, Tian H, Li H, Wang W, Chen X, Li X. Evaluation of the enhancing ability of three adjuvants for DNA vaccination using the porcine circovirus type 2 ORF2 (capsid) gene in mice. Virus Res 2012, 171:247-251.
20. Gamage LNA, McIntosh KA, Parker S, Harding J, Krakowka S, Ellis J. Efficacy of parenteral vaccination against porcine circovirus type 2 (PCV2) in seropositive piglets. CJVR 2012, 76:301-307. 3460609, 23543956.
21. Melkebeek V, Goddeeris BM, Cox E. ETEC vaccination in pigs. Vet Immunol Immunop 2013, 152:37-42.
22. Hur J, Lee JH. Development of a novel live vaccine delivering enterotoxigenic Escherichia coli fimbrial antigens to prevent post-weaning diarrhea in piglets. Vet Immunol Immunop 2012, 146:283-288.
23. Lambert M, Arsenault J, Poljak Z, D'Allaire S. Epidemiological investigations in regard to porcine reproductive and respiratory syndrome (PRRS) in Quebec, Canada. Part 2: prevalence and risk factors in breeding sites. Prev Vet Med 2012, 104:84-93. 10.1016/j.prevetmed.2011.11.002, 22169709.
24. Maes D, Nauwynck H, Rijsselaere T, Mateusen B, Vyt P, de Kruif A, Van Soom A. Diseases in swine transmitted by artificial insemination: an overview. Theriogenology 2008, 70(8):1337-1345. 10.1016/j.theriogenology.2008.06.018, 18657310.
25. Velasova M, Alarcon P, Williamson S, Wieland B. Risk factors for porcine reproductive and respiratory syndrome virus infection and resulting challenges for effective disease surveillance. BMC Vet Res 2012, 8:184-198. 10.1186/1746-6148-8-184, 3585917, 23034160.
26. Fablet C, Dorenlor V, Eono F, Eveno E, Jolly JP, Portier F, Bidan F, Madec F, Rose N. Noninfectious factors associated with pneumonia and pleuritis in slaughtered pigs from 143 farrow-to-finish pig farms. Prev Vet Med 2012, 104:271-280. 10.1016/j.prevetmed.2011.11.012, 22196500.
27. Donham KJ. Association of environmental air contaminants with disease and productivity in swine. Am J Vet Res 1991, 52:1723-1730.
28. Davies PR. One world, one health: the threat of emerging swine diseases. A North American perspective. Transbound Emerg Dis 2012, 59:18-26.